Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
OBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biode...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6173404?pdf=render |
_version_ | 1818368975068725248 |
---|---|
author | Yong Hoon Kim Ae-Young Her Myung Ho Jeong Byeong-Keuk Kim Sung-Jin Hong Dong-Ho Shin Jung-Sun Kim Young-Guk Ko Donghoon Choi Myeong-Ki Hong Yangsoo Jang |
author_facet | Yong Hoon Kim Ae-Young Her Myung Ho Jeong Byeong-Keuk Kim Sung-Jin Hong Dong-Ho Shin Jung-Sun Kim Young-Guk Ko Donghoon Choi Myeong-Ki Hong Yangsoo Jang |
author_sort | Yong Hoon Kim |
collection | DOAJ |
description | OBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biodegradable-polymer (BP)-coated biolimus-eluting stent (BES) in acute myocardial infarction (AMI) patients after successful percutaneous coronary intervention (PCI). METHODS:Finally, a total of 8357 AMI patients with current smoking underwent successful PCI with new-generation DES (ZES, EES, and BES) were enrolled and divided into three groups as ZES (n = 3199), EES (n = 3987), and BES group (n = 1171). The primary endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death (cardiac death [CD] or non-cardiac death), recurrent AMI (re-MI), any revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], and non-TVR). The secondary endpoint was the incidence of definite or probable stent thrombosis (ST). RESULTS:The 2-year adjusted hazard ratio (HR) of MACE for ZES vs. EES (1.055; 95% confidence interval [CI], 0.843-1.321; p = 0.638), ZES vs. BES (HR, 0.885; 95% CI, 0.626-1.251; p = 0.488), EES vs. BES (HR, 0.889; 95% CI, 0.633-1.250; p = 0.499), and ZES/EES vs. BES (HR, 0.891; 95% CI, 0.648-1.126; p = 0.480) were similar. The occurrence of ST after adjustment were also comparable. In addition, the 2-year adjusted HR for all-cause death, CD, re-MI, TLR, TVR, and non-TVR were not different. CONCLUSIONS:In this study, DP-DES and BP-DES showed comparable safety and efficacy during 2-year follow-up periods. Therefore, DP-DES or BP-DES are equally acceptable in AMI patients with current smoking undergoing PCI. |
first_indexed | 2024-12-13T23:16:29Z |
format | Article |
id | doaj.art-43fe56d112304694a6200276a076667c |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-13T23:16:29Z |
publishDate | 2018-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-43fe56d112304694a6200276a076667c2022-12-21T23:27:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020504610.1371/journal.pone.0205046Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.Yong Hoon KimAe-Young HerMyung Ho JeongByeong-Keuk KimSung-Jin HongDong-Ho ShinJung-Sun KimYoung-Guk KoDonghoon ChoiMyeong-Ki HongYangsoo JangOBJECTIVE:Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biodegradable-polymer (BP)-coated biolimus-eluting stent (BES) in acute myocardial infarction (AMI) patients after successful percutaneous coronary intervention (PCI). METHODS:Finally, a total of 8357 AMI patients with current smoking underwent successful PCI with new-generation DES (ZES, EES, and BES) were enrolled and divided into three groups as ZES (n = 3199), EES (n = 3987), and BES group (n = 1171). The primary endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death (cardiac death [CD] or non-cardiac death), recurrent AMI (re-MI), any revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], and non-TVR). The secondary endpoint was the incidence of definite or probable stent thrombosis (ST). RESULTS:The 2-year adjusted hazard ratio (HR) of MACE for ZES vs. EES (1.055; 95% confidence interval [CI], 0.843-1.321; p = 0.638), ZES vs. BES (HR, 0.885; 95% CI, 0.626-1.251; p = 0.488), EES vs. BES (HR, 0.889; 95% CI, 0.633-1.250; p = 0.499), and ZES/EES vs. BES (HR, 0.891; 95% CI, 0.648-1.126; p = 0.480) were similar. The occurrence of ST after adjustment were also comparable. In addition, the 2-year adjusted HR for all-cause death, CD, re-MI, TLR, TVR, and non-TVR were not different. CONCLUSIONS:In this study, DP-DES and BP-DES showed comparable safety and efficacy during 2-year follow-up periods. Therefore, DP-DES or BP-DES are equally acceptable in AMI patients with current smoking undergoing PCI.http://europepmc.org/articles/PMC6173404?pdf=render |
spellingShingle | Yong Hoon Kim Ae-Young Her Myung Ho Jeong Byeong-Keuk Kim Sung-Jin Hong Dong-Ho Shin Jung-Sun Kim Young-Guk Ko Donghoon Choi Myeong-Ki Hong Yangsoo Jang Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. PLoS ONE |
title | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. |
title_full | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. |
title_fullStr | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. |
title_full_unstemmed | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. |
title_short | Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. |
title_sort | impact of current smoking on 2 year clinical outcomes between durable polymer coated stents and biodegradable polymer coated stents in acute myocardial infarction after successful percutaneous coronary intervention data from the kamir |
url | http://europepmc.org/articles/PMC6173404?pdf=render |
work_keys_str_mv | AT yonghoonkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT aeyoungher impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT myunghojeong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT byeongkeukkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT sungjinhong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT donghoshin impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT jungsunkim impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT younggukko impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT donghoonchoi impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT myeongkihong impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir AT yangsoojang impactofcurrentsmokingon2yearclinicaloutcomesbetweendurablepolymercoatedstentsandbiodegradablepolymercoatedstentsinacutemyocardialinfarctionaftersuccessfulpercutaneouscoronaryinterventiondatafromthekamir |